White coat effect and white coat hypertension in community pharmacy practice

Blood Pressure Monitoring

Volumn 10, Issue 1, 2005, Pages 13-18

  Botomino, Andrea ^a   Martina, Benedict ^b   Ruf, Dominique ^a   Bruppacher, Rudolf ^a   Hersberger, Kurt E ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Blood pressure measurement; Community pharmacy services; Pharmaceutical care; White coat effect; White coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL PHARMACY; CLINICAL PRACTICE; COMMUNITY CARE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MALE; OUTPATIENT; PHARMACY; PRIORITY JOURNAL; SELF EXAMINATION; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; TUNICA ALBUGINEA; WHITE COAT HYPERTENSION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE DETERMINATION; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBSERVER VARIATION; OFFICE VISITS;

EID: 14644427756     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200502000-00004     Document Type: Article

References (24)

1. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 2:695-698.
2. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987; 9:209-215.
3. Pickering TG, Gerin W, Schwartz AR. What is the white-coat effect and how should it be measured? Blood Press Monit 2002; 7:293-300.
4. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R, et al. White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 1995; 8:790-798.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
6. Verdecchia P, Staessen JA, White WB, Imai Y, O'Brien ET. Properly defining white coat hypertension. Eur Heart J 2002; 23:106-109.
7. Estlinbaum T, Martina B, Battegay E. White coat hypertension. Schweiz Med Forum 2002; 15:360-365.
8. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
9. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98:1892-1897.
10. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and non-sustained systolic hypertension. Circulation 2000; 102:1139-1144.
11. Palatini P, Penzo M, Canali C, Dorigatti F, Pessina AC. Interactive action of the white-coat effect and the blood pressure levels on cardiovascular complications in hypertension. Am J Med 1997; 103:208-216.
12. Owens PE, Lyons SP, Rodriguez SA, O'Brien ET. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J Hum Hypertens 1998; 12:743-748.
13. Selenta C, Hogan BE, Linden W. How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat normotension. Arch Fam Med 2000; 9:533-540.
14. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131:564-572.
15. Stergiou GS, Zourbaki AS, Skeva II, Mountokalakis TD. White coat effect detected using self-monitoring of blood pressure at home: comparison with ambulatory blood pressure. Am J Hypertens 1998; 11:820-827.
16. Hond ED, Celis H, Fagard R, Keary L, Leeman M, O'Brien E, et al. Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. J Hypertens 2003; 21:717-722.
17. Nordmann A, Frach B, Walker T, Martina B, Battegay E. Comparison of self-reported home blood pressure measurements with automatically stored values and ambulatory blood pressure. Blood Press 2000; 9:200-205.
18. Johnson KA, Partsch DJ, Rippole LL, McVey DM. Reliability of self-reported blood pressure measurements. Arch Intern Med 1999; 159:2689-2693.
19. Bachmann LM, Steurer J, Holm D, Vetter W. To what extent can we trust home blood pressure measurement? A randomized, controlled trial. J Clin Hypertens 2002; 4:405-407.
20. Mengden T, Hernandez Medina RM, Beltran B, Alvarez E, Kraft K, Vetter H. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens 1998; 11:1413-1417.
21. Altunkan S, Iliman N, Altunkan E. Accuracy of the new wrist blood pressure monitor (Omron 637 IT), for blood pressure measurement. J Hypertens 2003; 21(suppl 4):S22.
22. Myers MG, Oh PI, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens 1995; 8:591-597.
23. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40:795-796.
24. Segre CA, Ueno RK, Warde KR, Accorsi TA, Miname MH, Chi CK, et al. White-coat hypertension and normotension in the League of Hypertension of the Hospital das Clinicas, FMUSP: prevalence, clinical and demographic characteristics. Arq Bras Cardiol 2003; 80:117-126.